- Category
- Micro (2021-22)
- Udyam number
- UDYAM-KR-03-0106285

Alactis Pharmaceuticals Private Limited
About Alactis Pharmaceuticals Private Limited
Data last updated:
Alactis Pharmaceuticals Private Limited is a private limited company based in Bengaluru, Karnataka, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 04 June 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U51909KA2021PTC148176. Its GSTIN is 29AAVCA3038Q1ZS (Karnataka).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Bandhana and Pallavi.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No.29 16th Cross Nagarabhavi 2nd Phase Malagala Bengaluru – 560091, Karnataka, India – 560091.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.01 Cr, a decline of 33% compared to the previous year. For the same year it recorded a net loss of ₹9.1 Lakh (net margin -9%) and EBITDA of -₹8.43 Lakh (EBITDA margin -8.3%).
Alactis Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0106285).
Company details
Recognitions & Rankings of Alactis Pharmaceuticals
Contact details
Alactis Pharmaceuticals Private Limited's registered office is in Bengaluru, Karnataka.
- Registered AddressNo.29 16th Cross Nagarabhavi 2nd Phase Malagala Bengaluru – 560091, Karnataka, India – 560091
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Alactis Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Alactis Pharmaceuticals Private Limited, buy the company report.
Financials of Alactis Pharmaceuticals Private Limited
FY 2025 filings availableAlactis Pharmaceuticals Private Limited reported revenue of ₹1.01 Cr (down 33% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 33% in the latest year. EBITDA rose 3% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹8.43 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹9.1 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -8.3% | ||
| Net Profit Margin | -9% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Alactis Pharmaceuticals Private Limited, buy the company report.
Board of directors of Alactis Pharmaceuticals Private Limited
Alactis Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bandhana Also directs: Medicine Zone Private Limited | Director | 04 Jun 2021 | 5 Years 4 Months | Current |
| Pallavi Also directs: Medicine Zone Private Limited | Director | 04 Jun 2021 | 5 Years 4 Months | Current |
| Mahavir Manhas Singh Also directs: Medicine Zone Private Limited | Director | 15 Nov 2022 | 3 Years 11 Months | Current |
Legal cases
No court or tribunal cases involving Alactis Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Alactis Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Alactis Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAVCA3038Q1ZS | Karnataka | Active | 13 Jul 2021 |
To see the full GST registrations and return filing status of Alactis Pharmaceuticals Private Limited, buy the company report.
Recent activity
Alactis Pharmaceuticals Private Limited has 3 board changes on record since 2021: 3 appointments. The latest: Mahavir Manhas Singh was appointed as Director on 15 Nov 2022.
Frequently asked questions
Alactis Pharmaceuticals is an active private limited company based in Bengaluru, Karnataka, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 04 June 2021 (5+ years old) and is registered under CIN U51909KA2021PTC148176.
Alactis Pharmaceuticals has 3 current directors:
- Bandhana - Director
- Pallavi - Director
- Mahavir Manhas Singh - Director
The latest financial statements of Alactis Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Alactis Pharmaceuticals is 29AAVCA3038Q1ZS, registered in Karnataka.
The CIN (Corporate Identification Number) of Alactis Pharmaceuticals is U51909KA2021PTC148176. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Alactis Pharmaceuticals was incorporated on 04 June 2021, making it 5+ years old. It is registered with the Registrar of Companies, Bangalore.
Mahavir Manhas Singh was appointed as Director on 15 Nov 2022. Bandhana was appointed as Director on 04 Jun 2021. Pallavi was appointed as Director on 04 Jun 2021.
Yes, Alactis Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-03-0106285).
The registered office of Alactis Pharmaceuticals is at No.29 16th Cross Nagarabhavi 2nd Phase Malagala Bengaluru – 560091, Karnataka, India – 560091.
Alactis Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.